Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease

WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)--Jul 24,
2010 - Eisai Inc. and Pfizer Inc announced today that
the U.S. Food and Drug Administration (FDA) approved a new
once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for
the...